pocketful logo
Procter & Gamble Health Ltd logo

Procter & Gamble Health Ltd

NSE: PGHL BSE: 500126

₹4898

(0.12%)

Mon, 16 Mar 2026, 01:04 pm

mtf coin illustrationMTF 5x

Procter & Gamble Health Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    8053.69

  • Net Profit

    234.41

  • P/B

    15.90

  • Sector P/E

    40.12

  • P/E

    27.31

  • EV/EBITDA

    25.42

  • Debt/Equity (Industry)

    0.09

  • Interest Cover (Industry)

    41.16

  • ROCE (Industry)

    22.87

  • RONW (Industry)

    18.28

  • ROE

    58.14

  • ROCE

    71.75

  • Debt/Equity

    0.02

  • EPS (TTM)

    176.81

  • Dividend Yield

    2.58

  • Book Value

    373.34

  • Interest Cover

    725.70

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (4.1x coverage).
  • Procter & Gamble Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Procter & Gamble Health is profitable, therefore cash runway is not a concern.
  • Procter & Gamble Health is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Procter & Gamble Health's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Procter & Gamble Health's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • The average tenure for the Procter & Gamble Health board of directors is less than 3 years, this suggests a new board.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters51.8251.8251.8251.8251.82
FII6.977.246.996.877.01
DII13.8413.9114.1614.2114.71
Public27.3727.0427.0327.1126.46
Government00000

Read More

Technical Analysis

RSI

40.51

MACD

-108.63

50 DMA

5238.85

200 DMA

5809.08

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic6596.835858.835379.675120.834641.674382.833644.83
Fibonacci5858.835576.925402.755120.834838.924664.754382.83
Camarilla5103.455035.804968.155120.834832.854765.204697.55

Pivots Level: Classic

R3

+1476

6596.83

R2

+738

5858.83

R1

+258.83

5379.67

5120.83
5120.83
Pivot Point
LTP: 4902.80

S1

-479.17

4641.67

S2

-738

4382.83

S3

-1476

3644.83

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    4910.31

  • 20-EMA

    4985.87

  • 30-EMA

    5063.31

  • 50-EMA

    5202.16

  • 100-EMA

    5434.06

  • 200-EMA

    5569.56

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
06 Feb 2026board-meetingsQuarterly Results
06 Feb 2026dividend₹110.00 Dividend /Share12 Feb 2026
12 Jan 2026dividendSpecial Dividend - Rs. - 5012 Feb 2026
05 Nov 2025board-meetingsQuarterly Results, Interim Dividend
06 Aug 2025agm
22 Jul 2025dividendFinal Dividend - Rs. - 4522 Aug 2025
29 May 2025dividend₹45.00 Dividend /Share22 Aug 2025
12 Feb 2025dividend₹80.00 Dividend /Share21 Feb 2025
21 Jan 2025dividendInterim Dividend - Rs. - 8021 Feb 2025
28 Oct 2024dividendAnnual General Meeting/Dividend - Rs 60 Per Share29 Nov 2024

Read More

Peer Comparison

Procter & Gamble Health Ltd logo

Procter & Gamble Health Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Procter & Gamble Health Ltd About

Procter & Gamble Health is in the business of manufacturing and marketing of pharmaceuticals.

Industry

Pharmaceuticals - Multinational

Founded

1967

Headquarters

CEO

S Madhavan

Employees

Contact

Website icon

Website

http://www.pghealthindia.com

Email icon

Email

investorgrievance.im@pg.com

Phone icon

Phone

91-22-62109000

Location icon

Location

Godrej One 8th Floor, Projshanagar Vikhroli (East), Mumbai, Maharashtra, 400079

Read More

Procter & Gamble Health Ltd Company History

YearHistory
2020
  • P&G Health partnered with PHFI for Digital Health Project at Goa under SEHAT CSR Program.
2021
  • P&G Health partnered with Tata Trusts to advance nutritional status of women and children in Andhra Pradesh.
  • P&G Health commemorated Iron Deficiency Day with GUINNESS WORLD RECORDS achievement.
2022
  • P&G Health launched Na Na Anemia Bus Yatra across 20 cities for Iron Deficiency Anemia awareness.
  • P&G Health partnered with Lakshya and Recycle India Foundation for sustainable pharmacy waste management.
  • P&G Health brought global nerve care experts together for Peripheral Neuropathy awareness.
  • P&G Health partnered with Apnalaya to improve maternal and newborn health in Mumbai slums.
2023
  • P&G Health partnered with Indian Academy of Pediatrics for Sankalp: Sampoorna Swasthya school healthcare initiative.
  • P&G Health launched Mobile Healthcare Unit with HelpAge India in Guwahati.
  • P&G Health collaborated with Indian Medical Association to launch VitaM.I.N.D.S conclave.
  • Polybion celebrated World Health Day and launched Pragati Utsav for Vitamin B Deficiency awareness.
2024
  • P&G Health and HelpAge India collaborated to improve healthcare access in Palghar.
  • P&G Health's Nasivion entered Asia Book of Records.
  • P&G Health achieved GUINNESS WORLD RECORDS title for largest online photo album of people wearing pin badges.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
SMALLER CAP WORLD FUND INCSell11449854913 Jan 2014
AMERICAN FUND INSURANCE A/C AMERICAN INSURANCE SERIES GLOBALSell14184954913 Jan 2014
RELIANCE MUTUAL FUND A/C RELIANCE PHARMA FUNDBuy25650054913 Jan 2014
HDFC MUTUAL FUND AC HDFC MONTHLY INCOME PLAN LONG TERMSell24899473006 Oct 2010
SBI MUTUAL FUND AC MAGNUM SECTOR FUND UMBRELLA CONTRABuy249000729.9806 Oct 2010
JMP SECURITIES PVT LTDSell105340587.1616 Oct 2009
HDFC TRUSTEE CO.LTD A/C HDFC MUTUAL FUND-MIP LONG TERM PLANBuy100353570.7316 Oct 2009
JMP SECURITIES PVT LTDBuy131735587.2516 Oct 2009
AMERICAN FUNDS INSURANCE SERIESGLOBAL CAPITALIZATION FUNDBuy300000347.4906 May 2009
HDFC MUTUAL FUNDSell300000347.4906 May 2009

Read More

Procter & Gamble Health Ltd News

P&G Health Declares ₹160 Per Share Dividend

Procter & Gamble Health Limited has announced a dividend payment of ₹160 per share for its shareholders, reflecting the company's commitment to returning value to investors.

06 Feb 2026

co actions results

P&G Health Q3 Net Profit Drops 14.6% to ₹776M

Procter & Gamble Health reports Q3 standalone net profit of ₹776 million, marking a year-on-year decline from ₹909 million in the corresponding quarter last year.

06 Feb 2026

co actions results

P&G Health Board to Consider Interim Dividend on Feb 6

Procter & Gamble Health Limited has revised its board meeting agenda for February 6, 2026, to include consideration of interim dividend declaration for FY26, in addition to previously scheduled matters.

21 Jan 2026

co actions results

Procter & Gamble Health Limited Appoints Shashank Srowthy as Executive Director

Procter & Gamble Health Limited confirmed the appointment of Shashank Srowthy as Executive Director for five years effective October 1, 2025, following shareholder approval through postal ballot on November 16, 2025. Srowthy brings 14 years of finance experience across PG operations in India, Dubai and Singapore, and holds no shares in the company nor any relationship with existing directors.

18 Nov 2025

corporate action

Procter & Gamble Health Limited Reports Quarterly Financial Results

Procter & Gamble Health Limited announced its unaudited financial results for the quarter ended September 30, 2025. The company reported revenue from operations of ₹54.5 crores for the quarter, compared to ₹54.7 crores in the previous quarter and ₹51.1 crores in the corresponding quarter of the previous year. Net profit for the quarter stood at ₹88.6 crores, significantly higher than ₹66.2 crores in the previous quarter and ₹82.5 crores in the same quarter last year. For the six-month period ended September 30, 2025, revenue was ₹109.3 crores with net profit of ₹154.8 crores. The company's earnings per share for the quarter was ₹53.34. Cash and cash equivalents increased to ₹279.3 crores as of September 30, 2025, from ₹182.3 crores as of March 31, 2025. The Board of Directors approved these results at a meeting held on November 5, 2025.

05 Nov 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800